Health Diagnostic to distribute sale proceeds via liquidation plan

By Caroline Salls

Pittsburgh, Jan. 5 – Health Diagnostic Laboratory, Inc. filed its plan of liquidation and related disclosure statement on Jan. 4 with the U.S. Bankruptcy Court for the Eastern District of Virginia.

The company said the plan calls for the distribution of the proceeds from the liquidation of all remaining assets to creditors.

A liquidating trust will be established under the plan, and a liquidating trustee will be responsible for liquidating any assets that have not been liquidated before the plan effective date.

Treatment of creditors will include:

• Administrative claims, priority tax claims and priority non-tax claims will be paid in full in cash;

• Holders of secured claims will either be paid in full in cash or receive the collateral securing their claims;

• Holders of general unsecured claims will receive a share of series A liquidating trust interests, which will entitle them to trust distributions until the principal amount of the claims is paid in full and post-bankruptcy interest at the federal judgment rate after the principal amount is paid in full;

• Holders of subordinated claims will receive series B liquidating trust interests; and

• Interest holders will receive series C liquidating trust interests. All interests in one debtor that are held by another debtor will be cancelled without distribution.

The disclosure statement hearing is scheduled for Feb. 11.

Health Diagnostic, a Richmond, Va.-based blood testing company, filed for bankruptcy on June 7, 2015. The Chapter 11 case number is 15-32919.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.